Thalidomide-PEG4-COOH Catalog No.:M11605-2 methyl 2-hydroxy-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}imino)(phenyl)methyl]-1H-indole-6-carboxylate

methyl 2-hydroxy-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}imino)(phenyl)methyl]-1H-indole-6-carboxylate

Int J Pept Protein Res

InChi: InChI=1S/C21H12ClF5N2/c22-18-10-15(24)9-6-13(18)11-29-20(12-4-7-14(23)8-5-12)16-2-1-3-17(19(16)28-29)21(25

Characterization of Bromethalin and its Degradation Products in Veterinary Toxicology Samples by GC-MS-MS

24-diazahexacyclo[14

Thalidomide-PEG4-COOH Catalog No.:M11605-2 methyl 2-hydroxy-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}imino)(phenyl)methyl]-1H-indole-6-carboxylateThalidomide PEG4 COOH is a synthesized E3 ligase ligand linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. Product information Molecular Weight: 478. 45 Formula: C22H26N2O10 Chemical Name: 3 {2 [2 (2 {[2 (2, 6 dioxopiperidin 3 yl) 1, 3 dioxo 2, 3 dihydro 1H isoindol 5 yl]oxy}ethoxy)ethoxy]ethoxy}propanoic acid Smiles: OC(=O)CCOCCOCCOCCOC1=CC2=C(C=C1)C(=O)N(C1CCC(=O)NC1=O)C2=O InChiKey: